Examining Our Approach to COVID Vaccines
The race to develop vaccines for SARS-CoV-2 started soon after the COVID-19 pandemic emerged. A significant portion of the initial medications used messenger ribonucleic acid (mRNA) as their vector.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More